Pro Medicus Ltd
ASX:PME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pro Medicus Ltd
ASX:PME
|
AU |
|
Diamondrock Hospitality Co
NYSE:DRH
|
US |
|
Zhejiang Supor Co Ltd
SZSE:002032
|
CN |
|
Sanmina Corp
NASDAQ:SANM
|
US |
|
Arcutis Biotherapeutics Inc
NASDAQ:ARQT
|
US |
|
V
|
Venture Global Inc
NYSE:VG
|
US |
|
Toyota Industries Corp
TSE:6201
|
JP |
|
Anhui Deli Household Glass Co Ltd
SZSE:002571
|
CN |
|
C
|
CareCloud Inc
NASDAQ:CCLD
|
US |
|
JCDecaux SA
OTC:JCDXF
|
FR |
|
General Motors Co
NYSE:GM
|
US |
Wall St Price Targets
PME Price Targets Summary
Pro Medicus Ltd
According to Wall Street analysts, the average 1-year price target for PME is 205.177 AUD with a low forecast of 146.48 AUD and a high forecast of 259.35 AUD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PME's stock price target?
Price Target
205.177
AUD
According to Wall Street analysts, the average 1-year price target for PME is 205.177 AUD with a low forecast of 146.48 AUD and a high forecast of 259.35 AUD.
What is the Revenue forecast for Pro Medicus Ltd?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 8 years is 15%.
What is the Operating Income forecast for Pro Medicus Ltd?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Operating Income has been 67%. The projected CAGR for the next 8 years is 12%.
What is the Net Income forecast for Pro Medicus Ltd?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Net Income has been 38%. The projected CAGR for the next 8 years is 13%.
